KK
IRMD icon

KLP Kapitalforvaltning’s iRadimed IRMD Stock Holding History

KLP Kapitalforvaltning’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$558K Buy
5,800
+4,000
+222% +$400K ﹤0.01% 1379
2025
Q4 		$175K Sell
1,800
-300
-14% -$25.7K ﹤0.01% 1885
2025
Q3 		$149K Sell
2,100
-9,500
-82% -$633K ﹤0.01% 1923
2025
Q2 		$694K Sell
11,600
-5,200
-31% -$285K ﹤0.01% 1177
2025
Q1 		$882K Hold
16,800
– – ﹤0.01% 998
2024
Q4 		$924K Buy
+16,800
New +$884K ﹤0.01% 1032

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KLP Kapitalforvaltning's IRMD Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its iRadimed (IRMD) stake by 222% in Q1 2026, buying an estimated $400K and bringing the position to 5,800 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

KLP Kapitalforvaltning first reported a position in IRMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $924K in Q4 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • KLP Kapitalforvaltning held 5,800 shares of iRadimed worth $558K as of Q1 2026.
  • KLP Kapitalforvaltning bought 4,000 iRadimed shares in Q1 2026, an estimated $400K.
  • iRadimed made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1379 holding.
  • KLP Kapitalforvaltning first reported a position in iRadimed in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's iRadimed position peaked at $924K in Q4 2024.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.